Date | Research Question / Title | Unique ID | Research Team |
---|---|---|---|
April 21, 2021 | What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations? | EOC210302 RR | EOC |
April 21, 2021 | What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations? | EOC210302 RR Table | EOC |
October 7, 2021 | What is the current evidence and recommendations regarding COVID-19 vaccine booster shots (exceeding 2 doses) for the general population? | EOC210902 RR Table | EOC |
October 7, 2021 | What is the current evidence and recommendations regarding COVID-19 vaccine booster shots (exceeding 2 doses) for the general population? | EOC210902 RR | EOC |
March 10, 2022 | What is the safety/efficacy of the Novavax COVID-19 vaccine? | EOC220302 RR Table | EOC |
March 10, 2022 | What is the safety/efficacy of the Novavax COVID-19 vaccine? | EOC220302 RR | EOC |